Source: Annual Congress 2003 - Alpha-1 antitrypsin deficiency and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
V. Romberg, K. Roskos, J. Stocks, M. Phillips, M. Brantly (King of Prussia, San Carlos, Tyler, Gainseville). Pulmonary administration of alpha₁-antitrypsin for the treatment of Alpha₁-antitrypsin deficiency. Eur Respir J 2003; 22: Suppl. 45, 2480

Member's Comments

No comment yet.

Related content which might interest you: Bronchiectasis in alpha1-antitrypsin deficiency Source: International Congress 2019 – Chronic cough, a1-antitrypsin deficiency and other conditions Year: 2019 Diagnosis and management of alpha1-antitrypsin deficiency Source: Breathe 2007; 4: 38-46 Year: 2007 Efficacy of augmentation therapy for emphysema associated with alpha1-antitrypsin deficiency: enough is enough Source: Eur Respir J 2016; 47: 35-38 Year: 2016 Substitution therapy in Alpha-1 antitrypsin deficiency after lung transplantation Source: Eur Respir J 2006; 28: Suppl. 50, 724s Year: 2006 Lung deposition of inhaled alpha1-proteinase inhibitor in cystic fibrosis and alpha1-antitrypsin deficiency Source: Eur Respir J 2009; 33: 354-360 Year: 2009 Pulmonary disease in intermediate alpha1-antitrypsin deficient patients Source: International Congress 2017 – Clinical challenges in chronic lung diseases Year: 2017 Alpha-1-antitrypsin deficiency Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=139 Year: 2005 Current and future therapy of lung emphysema caused by alpha-1-antitrypsin deficiency Source: Annual Congress 2004 - Alpha-1-antitrypsin deficiency: Current knowledge and new frontiers Year: 2004 Exercise intolerance and lung emphysema in alpha-1 antitrypsin deficiency (AATD) Source: Annual Congress 2010 - Exercise in COPD Year: 2010 Lung function in relation to emphysema development in alpha-1 antitrypsin deficiency Source: International Congress 2019 – Insights into physiological diagnostic services Year: 2019 Effect of augmentation therapy on immune function of patients with severe Alpha1-antitrypsin deficiency Source: Annual Congress 2012 - COPD treatments: efficacy and safety Year: 2012 Occupational exposure in alpha-1-antitrypsin deficiency (AATD) Source: Annual Congress 2008 - COPD and other environment-related lung diseases Year: 2008 Endobronchial valve treatment in patients with severe emphysema due to alpha-1 antitrypsin deficiency. Source: International Congress 2019 – Interventional pulmonology: diagnostic techniques and obstructive airway disease Year: 2019 Aα360: A measure of disease and treatment efficacy in alpha-1-antitrypsin (A1AT) deficiency Source: Annual Congress 2010 - COPD: phenotyping and monitoring Year: 2010 Young adult with inherited PiMZ alpha-1-antitrypsin deficiency (A1ATD)-related bronchiectasis: characteristic of blood neutrophils and A1AT protein Source: International Congress 2016 – Translational studies in lung disease Year: 2016 Immune activation in α1 antitrypsin deficiency (AATD) emphysema: Beyond the protease/antiprotease hypothesis Source: Annual Congress 2012 - Mechanistic studies in airway cell biology Year: 2012 Alveolar nitric oxide correlates with lung volumes in patients with emphysema and Alpha-1 antitrypsin deficiency (AATD) Source: Eur Respir J 2006; 28: Suppl. 50, 223s Year: 2006 Alpha-1 antitrypsin deficiency – a potentially fatal disease Source: International Congress 2017 – Rare and common genetic variants of common and rare airway diseases Year: 2017